DDrare: Database of Drug Development for Rare Diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03626311 (ClinicalTrials.gov)	October 23, 2018	6/6/2018	Omega-3 Replacement With Krill Oil in Disease Management of SLE	A Double-Blind, Placebo-Controlled Randomized, Multicenter Study to Assess Changes in Omega-3 Index in Erythrocytes and Health Benefit After 24 Weeks of Daily Consumption of AKBM-3031 (Omega-3 Phospholipids From Krill), Followed by a 24 Week Open-Label Extension, in Patients With Systemic Lupus Erythematosus (SLE)	Systemic Lupus Erythematosus (SLE)	Dietary Supplement: AKBM-3031;Other: Placebo	Aker Biomarine Antarctic AS	Ampel BioSolutions, LLC	Recruiting	18 Years	N/A	All	76	N/A	United States;Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03626311
(ClinicalTrials.gov)

October 23, 2018

6/6/2018

Omega-3 Replacement With Krill Oil in Disease Management of SLE

A Double-Blind, Placebo-Controlled Randomized, Multicenter Study to Assess Changes in Omega-3 Index in Erythrocytes and Health Benefit After 24 Weeks of Daily Consumption of AKBM-3031 (Omega-3 Phospholipids From Krill), Followed by a 24 Week Open-Label Extension, in Patients With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE)

Dietary Supplement: AKBM-3031;Other: Placebo

Aker Biomarine Antarctic AS

Ampel BioSolutions, LLC

Recruiting

18 Years

N/A

All

N/A

United States;Canada